MarketAxess heads into its August 5 earnings date with short sellers quietly rebuilding positions and the Street in broad retreat on price targets — yet the stock has gained 4.5% on the week, creating a visible tension between market action and analyst sentiment.
The short interest story is the most interesting number this week. Shorts on MKTX rose 11% over seven days to 6.6% of free float — a meaningful single-week jump that stands out even though the 30-day trend is still modestly lower. The rebuild is recent and sharp: shares short troughed around 2.17 million at the start of July and climbed back toward 2.44 million by July 7. Borrow conditions do nothing to discourage this. Availability is extraordinarily loose at over 1,300% — there are roughly 13 shares available to borrow for every one already lent out — and cost to borrow has fallen nearly 27% on the week to just 0.39%. Adding positions is frictionless right now. The ORTEX short score has ticked up to 47.1 from 44.4 a week ago, confirming the direction, though the absolute level is mid-range rather than extreme.
Options positioning is only slightly more cautious than usual. The put/call ratio edged up to 0.056, about 1.4 standard deviations above its 20-day average — a mild uptick but not a defensive alarm. For context, the 52-week high on the PCR is 0.67, so options traders are nowhere close to pricing in genuine downside fear. The borrow market and the options market are telling the same story: positioning is firm but not crowded, and the cost of conviction on either side remains low.
The Street's direction of travel is harder to ignore. Two bellwether moves this week tell the story. Goldman Sachs cut its target from $168 to $130 on June 30, keeping a Neutral rating — a 23% reduction that sent a clear signal on near-term earnings power. Then on July 8, UBS trimmed its Buy-rated target from $215 to $200. Both moves reflect the same fundamental anxiety: the bear case centers on an EPS reset, with 2026 estimates now around $8.26 versus $8.89 previously, driven by higher taxes and softer fee-per-million metrics. At $118.60, the stock trades at roughly a 13x trailing P/E and an EV/EBITDA near 8x — both multiples have contracted around 17–21% over the past 30 days, which goes some way toward explaining the week's bounce. The consensus mean target is $174.64, implying significant upside on paper, but the direction of revision has been uniformly lower. B of A upgraded to Neutral from Underperform in mid-June but held its $170 target. That upgrade, and the Keefe Bruyette reinstatement at Outperform with a $195 target from April, represent the bull case anchors: secular tailwinds in fixed-income electronification, the block trading initiative in US Credit, and expansion into municipal markets. Neither camp has walked away entirely; they've simply repriced lower.
On the ownership side, Millennium Management added 785,523 shares in Q1 — roughly a threefold increase in its position — while Neuberger Berman added 416,390 shares through June 17. BlackRock and Vanguard entities are collectively the two largest holders with combined ownership above 20%. Against that constructive institutional backdrop, recent insider activity has been net sellers: the CFO, CEO, and General Counsel each sold modest amounts between February and June, all at prices well above current levels. The selling was at $146–$192 per share; the stock now trades at $118.60, meaning insiders were exiting into strength that has since unwound.
Earnings history adds a cautionary note without predicting anything. The most recent Q1 print on May 7 produced a flat-to-negative reaction — the stock fell 0.9% on the day and was down 5.6% five days later. The earlier Q4 event in early June showed a near-zero day-one move but a 2.9% five-day gain. The pattern is not violent, but it tilts negative on the immediate print. With the next event on August 5, the key question is whether the downward analyst revisions have already sufficiently reset expectations, or whether fee-per-million trends deliver another disappointment. That gap between the $118.60 price and a Wall Street target cluster in the $130–$200 range is the number to watch as August approaches.
See the live data behind this article on ORTEX.
Open MKTX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
